| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |